Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Cash & Current Investments: 2016-2023

Historic Cash & Current Investments for Solid Biosciences (SLDB) over the last 8 years, with Dec 2023 value amounting to $123.6 million.

  • Solid Biosciences' Cash & Current Investments rose 19.76% to $171.1 million in Q3 2024 from the same period last year, while for Sep 2024 it was $691.1 million, marking a year-over-year decrease of 1.60%. This contributed to the annual value of $123.6 million for FY2023, which is 42.15% down from last year.
  • According to the latest figures from FY2023, Solid Biosciences' Cash & Current Investments is $123.6 million, which was down 42.15% from $213.7 million recorded in FY2022.
  • Solid Biosciences' 5-year Cash & Current Investments high stood at $213.7 million for FY2022, and its period low was $83.5 million during FY2019.
  • In the last 3 years, Solid Biosciences' Cash & Current Investments had a median value of $207.8 million in 2021 and averaged $181.7 million.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first skyrocketed by 85.27% in 2020, then crashed by 42.15% in 2023.
  • Over the past 5 years, Solid Biosciences' Cash & Current Investments (Yearly) stood at $83.5 million in 2019, then surged by 85.27% to $154.7 million in 2020, then soared by 34.27% to $207.8 million in 2021, then grew by 2.86% to $213.7 million in 2022, then tumbled by 42.15% to $123.6 million in 2023.